Please use this identifier to cite or link to this item:
https://wslhd.intersearch.com.au/wslhdjspui/handle/1/8393| Title: | Pembrolizumab: a potential game-changer in the treatment of advanced hepatocellular carcinoma |
| Authors: | Shek, Dmitrii;Ahlenstiel, Golo |
| WSLHD Author: | Shek, Dmitrii;Ahlenstiel, Golo |
| Subjects: | Oncology;Hepatology |
| Issue Date: | 2023 |
| Citation: | Chinese Clinical Oncology 12(5):47, 2023 |
| URI: | https://wslhd.intersearch.com.au/wslhdjspui/handle/1/8393 |
| DOI: | https://dx.doi.org/10.21037/cco-23-44 |
| Journal: | Chinese Clinical Oncology |
| Type: | Journal Article |
| Department: | Oncology Gastroenterology and Hepatology |
| Facility: | Blacktown Mount Druitt Westmead Auburn |
| Affiliated Organisations: | Westmead Institute for Medical Research, Sydney, NSW, Australia Blacktown Mt Druitt Hospital, Sydney, NSW, Australia |
| Keywords: | Carcinoma, Hepatocellular Liver Neoplasms Antibodies, Monoclonal, Humanized |
| Appears in Collections: | Blacktown Mount Druitt Hospital |
Files in This Item:
There are no files associated with this item.
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.